CN1061142C - 一种基于微粒光散射的免疫分析方法 - Google Patents
一种基于微粒光散射的免疫分析方法 Download PDFInfo
- Publication number
- CN1061142C CN1061142C CN93119931A CN93119931A CN1061142C CN 1061142 C CN1061142 C CN 1061142C CN 93119931 A CN93119931 A CN 93119931A CN 93119931 A CN93119931 A CN 93119931A CN 1061142 C CN1061142 C CN 1061142C
- Authority
- CN
- China
- Prior art keywords
- microsphere
- analyte
- potpourri
- dimension
- light scattering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003018 immunoassay Methods 0.000 title claims abstract description 18
- 239000002245 particle Substances 0.000 title claims description 30
- 230000002776 aggregation Effects 0.000 title description 2
- 238000004220 aggregation Methods 0.000 title description 2
- 239000004005 microsphere Substances 0.000 claims abstract description 166
- 239000012491 analyte Substances 0.000 claims abstract description 153
- 239000012530 fluid Substances 0.000 claims abstract description 72
- 230000027455 binding Effects 0.000 claims abstract description 57
- 239000002923 metal particle Substances 0.000 claims abstract description 57
- 239000000427 antigen Substances 0.000 claims abstract description 31
- 102000036639 antigens Human genes 0.000 claims abstract description 31
- 108091007433 antigens Proteins 0.000 claims abstract description 31
- 238000009826 distribution Methods 0.000 claims abstract description 28
- 230000005764 inhibitory process Effects 0.000 claims abstract description 9
- 230000008859 change Effects 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 96
- 238000000149 argon plasma sintering Methods 0.000 claims description 66
- 238000004458 analytical method Methods 0.000 claims description 60
- 229910052751 metal Inorganic materials 0.000 claims description 33
- 239000002184 metal Substances 0.000 claims description 33
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- 239000000376 reactant Substances 0.000 claims description 16
- 239000011541 reaction mixture Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 230000009871 nonspecific binding Effects 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- 206010070834 Sensitisation Diseases 0.000 claims description 3
- 230000008313 sensitization Effects 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- 230000002860 competitive effect Effects 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 230000021615 conjugation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 238000003556 assay Methods 0.000 abstract description 3
- 239000000084 colloidal system Substances 0.000 abstract description 3
- 238000006073 displacement reaction Methods 0.000 abstract description 3
- 238000011002 quantification Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 46
- 239000004816 latex Substances 0.000 description 40
- 229920000126 latex Polymers 0.000 description 40
- 210000002966 serum Anatomy 0.000 description 22
- 238000013016 damping Methods 0.000 description 17
- 102000011923 Thyrotropin Human genes 0.000 description 16
- 108010061174 Thyrotropin Proteins 0.000 description 16
- 230000035945 sensitivity Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 230000002411 adverse Effects 0.000 description 7
- 230000004520 agglutination Effects 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 230000002452 interceptive effect Effects 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000013527 degreasing agent Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000012447 hatching Effects 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000008141 laxative Substances 0.000 description 3
- 230000002475 laxative effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 102000009843 Thyroglobulin Human genes 0.000 description 2
- 108010034949 Thyroglobulin Proteins 0.000 description 2
- 230000004523 agglutinating effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 2
- 229960005156 digoxin Drugs 0.000 description 2
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229960002175 thyroglobulin Drugs 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 101000800133 Homo sapiens Thyroglobulin Proteins 0.000 description 1
- 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- 241001352546 Morrisonia latex Species 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 101710182223 Toxin B Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000009123 feedback regulation Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 102000047688 human TG Human genes 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 229910000765 intermetallic Inorganic materials 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000005497 microtitration Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000013374 right angle light scattering Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 238000007817 turbidimetric assay Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N15/0205—Investigating particle size or size distribution by optical means
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99490392A | 1992-12-22 | 1992-12-22 | |
| US994,903 | 1992-12-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1092866A CN1092866A (zh) | 1994-09-28 |
| CN1061142C true CN1061142C (zh) | 2001-01-24 |
Family
ID=25541198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93119931A Expired - Fee Related CN1061142C (zh) | 1992-12-22 | 1993-12-21 | 一种基于微粒光散射的免疫分析方法 |
Country Status (9)
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200820B1 (en) * | 1992-12-22 | 2001-03-13 | Sienna Biotech, Inc. | Light scatter-based immunoassay |
| DK0925494T3 (da) * | 1996-09-04 | 2002-07-01 | Scandinavian Micro Biodevices | Mikrostrømningssystem til partikelseparation og analyse |
| US6165798A (en) * | 1996-10-10 | 2000-12-26 | University Of British Columbia | Optical quantification of analytes in membranes |
| US5858648A (en) * | 1996-11-04 | 1999-01-12 | Sienna Biotech, Inc. | Assays using reference microparticles |
| GB9707096D0 (en) * | 1997-04-08 | 1997-05-28 | Smithkline Beecham Plc | Novel device |
| EP0919568A1 (en) | 1997-12-01 | 1999-06-02 | Sorin Diagnostics S.r.l. | Escape mutant of the surface antigen of hepatitis B virus |
| US6127130A (en) | 1998-03-13 | 2000-10-03 | The United States Of America As Represented By The Secretary Of The Navy | Multiassay method for determining the concentrations of antigens and interferants |
| CA2254223A1 (en) * | 1998-11-16 | 2000-05-16 | Biophys, Inc. | Device and method for analyzing a biologic sample |
| US6221579B1 (en) * | 1998-12-11 | 2001-04-24 | Kimberly-Clark Worldwide, Inc. | Patterned binding of functionalized microspheres for optical diffraction-based biosensors |
| US20050148101A1 (en) * | 1999-01-23 | 2005-07-07 | Bamdad Cynthia C. | Interaction of colloid-immobilized species with species on non-colloidal structures |
| WO2000043791A2 (en) * | 1999-01-25 | 2000-07-27 | Minerva Biotechnologies Corporation | Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| JP2002535656A (ja) * | 1999-01-23 | 2002-10-22 | ミナーヴァ・バイオテクノロジーズ・コーポレーション | コロイド固定化種と非コロイド構造上の種との相互作用 |
| FR2797690B1 (fr) * | 1999-08-20 | 2001-10-12 | Bio Merieux | Procede de detection d'un analyte et necessaire pour la mise en oeuvre de ce procede |
| US6392327B1 (en) | 2000-03-29 | 2002-05-21 | James L. Sackrison | Sonic transducer and feedback control method thereof |
| WO2001096604A2 (en) * | 2000-06-12 | 2001-12-20 | Genicon Sciences Corporation | Assay for genetic polymorphisms using scattered light detectable labels |
| CA2423630C (en) * | 2000-10-03 | 2011-12-06 | Minerva Biotechnologies Corporation | Magnetic in situ dilution |
| US20020155618A1 (en) * | 2001-01-17 | 2002-10-24 | O'hagan David | Methods of analyzing and sorting one or more analytes |
| US7939283B2 (en) * | 2001-11-01 | 2011-05-10 | Fisher Scientific Company L.L.C. | Analyte binding turbidity assay |
| US6837171B1 (en) | 2002-04-29 | 2005-01-04 | Palmer/Snyder Furniture Company | Lightweight table with unitized table top |
| US20030119203A1 (en) | 2001-12-24 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay devices and methods for conducting assays |
| US8367013B2 (en) | 2001-12-24 | 2013-02-05 | Kimberly-Clark Worldwide, Inc. | Reading device, method, and system for conducting lateral flow assays |
| US7771922B2 (en) | 2002-05-03 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Biomolecule diagnostic device |
| US7214530B2 (en) | 2002-05-03 | 2007-05-08 | Kimberly-Clark Worldwide, Inc. | Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices |
| US7285424B2 (en) | 2002-08-27 | 2007-10-23 | Kimberly-Clark Worldwide, Inc. | Membrane-based assay devices |
| JP4087200B2 (ja) * | 2002-09-17 | 2008-05-21 | ユニバーサル・バイオ・リサーチ株式会社 | 粒子複合体及び該粒子複合体の作製方法 |
| US7122384B2 (en) * | 2002-11-06 | 2006-10-17 | E. I. Du Pont De Nemours And Company | Resonant light scattering microparticle methods |
| KR20040044336A (ko) * | 2002-11-12 | 2004-05-28 | 마쯔시다덴기산교 가부시키가이샤 | 특이결합반응 측정방법과 이에 이용하는 시약키트 및특이결합반응 측정장치 |
| US7781172B2 (en) | 2003-11-21 | 2010-08-24 | Kimberly-Clark Worldwide, Inc. | Method for extending the dynamic detection range of assay devices |
| US7247500B2 (en) | 2002-12-19 | 2007-07-24 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in membrane-based assay devices |
| US20040197819A1 (en) | 2003-04-03 | 2004-10-07 | Kimberly-Clark Worldwide, Inc. | Assay devices that utilize hollow particles |
| US7851209B2 (en) | 2003-04-03 | 2010-12-14 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in assay devices |
| US20050112703A1 (en) | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
| US7943395B2 (en) | 2003-11-21 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Extension of the dynamic detection range of assay devices |
| US7713748B2 (en) | 2003-11-21 | 2010-05-11 | Kimberly-Clark Worldwide, Inc. | Method of reducing the sensitivity of assay devices |
| WO2005057169A2 (en) * | 2003-12-05 | 2005-06-23 | Trellis Bioscience, Inc. | Homogeneous competition assays |
| US7943089B2 (en) | 2003-12-19 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Laminated assay devices |
| US7796266B2 (en) | 2004-04-30 | 2010-09-14 | Kimberly-Clark Worldwide, Inc. | Optical detection system using electromagnetic radiation to detect presence or quantity of analyte |
| US7815854B2 (en) | 2004-04-30 | 2010-10-19 | Kimberly-Clark Worldwide, Inc. | Electroluminescent illumination source for optical detection systems |
| JP4730304B2 (ja) * | 2004-05-20 | 2011-07-20 | 和光純薬工業株式会社 | ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法 |
| US7521226B2 (en) | 2004-06-30 | 2009-04-21 | Kimberly-Clark Worldwide, Inc. | One-step enzymatic and amine detection technique |
| US7170035B2 (en) * | 2004-08-04 | 2007-01-30 | Hottboxx Llc | Heated construction box |
| ITMI20041800A1 (it) * | 2004-09-21 | 2004-12-21 | Univ Degli Studi Milano | Netodo di misurazione di interazioni molecolari con lls |
| JP5426881B2 (ja) * | 2005-11-12 | 2014-02-26 | プラットフォーム・ダイアグノスティクス・リミテッド | 凝集アッセイ |
| ES2883201T3 (es) * | 2006-04-08 | 2021-12-07 | Hoffmann La Roche | Análisis de datos ópticos con la ayuda de histogramas |
| US7776618B2 (en) * | 2007-03-01 | 2010-08-17 | Church & Dwight Co., Inc. | Diagnostic detection device |
| ITPO20070023A1 (it) | 2007-09-26 | 2009-03-27 | Hospitex Diagnostics S R L | Metodo e dispositivo per l'analisi multipla ad alta sensibilita di campioni biologici |
| WO2011084697A2 (en) * | 2009-12-17 | 2011-07-14 | Abaxis, Inc. | Novel assays for detecting analytes in samples and kits and compositions related thereto |
| JP2013533469A (ja) | 2010-05-25 | 2013-08-22 | アリックス インク | 免疫診断における生物学的および化学的分析および用途における粒子の位置的自由度の検出のための方法および装置 |
| US9618523B2 (en) * | 2013-02-28 | 2017-04-11 | Siemens Healthcare Diagnostics Inc. | Methods and reagents for determining isomeric analytes |
| US20150046862A1 (en) * | 2013-08-11 | 2015-02-12 | Silicon Graphics International Corp. | Modifying binning operations |
| US11144184B2 (en) | 2014-01-23 | 2021-10-12 | Mineset, Inc. | Selection thresholds in a visualization interface |
| EP4050322B1 (en) * | 2016-08-04 | 2024-05-29 | Malvern Panalytical Limited | Method of characterising particles suspended in a fluid dispersant by light diffraction, processor and machine-readable, non-transient storage medium |
| CN110998294A (zh) * | 2017-08-10 | 2020-04-10 | Jvc建伍株式会社 | 分析方法和分析装置 |
| CN111398577A (zh) * | 2020-06-08 | 2020-07-10 | 南京颐兰贝生物科技有限责任公司 | 一种定量免疫检测方法 |
| EP4409288A1 (en) * | 2021-10-01 | 2024-08-07 | PNP Research LLC | Optical background suppression in binding assays that employ polymeric microspheres |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3873204A (en) * | 1970-01-14 | 1975-03-25 | Bio Physics Systems Inc | Optical extinction photoanalysis apparatus for small particles |
| NL7807532A (nl) * | 1978-07-13 | 1980-01-15 | Akzo Nv | Metaal-immunotest. |
| DE2918342A1 (de) * | 1979-05-07 | 1980-11-20 | Behringwerke Ag | Latex-reagenz |
| JPS57175957A (en) * | 1981-04-24 | 1982-10-29 | Chugai Pharmaceut Co Ltd | Measuring method and device for antigen- antibody reaction |
| US4480042A (en) * | 1981-10-28 | 1984-10-30 | E. I. Du Pont De Nemours And Company | Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays |
| US4581334A (en) * | 1983-04-25 | 1986-04-08 | Ortho Diagnostics Systems, Inc. | Simultaneous detection of leukocyte phagocytic and killing ability |
| AU7385387A (en) * | 1986-06-09 | 1987-12-10 | Ortho Diagnostic Systems Inc. | Immunoassay using detection of colloidal gold |
| US5017009A (en) * | 1986-06-26 | 1991-05-21 | Ortho Diagnostic Systems, Inc. | Scattered total internal reflectance immunoassay system |
| EP0287665B1 (en) * | 1986-09-22 | 1996-07-31 | Nippon Telegraph And Telephone Corporation | Laser magnetic immunoassay method and apparatus therefor |
| US4853335A (en) * | 1987-09-28 | 1989-08-01 | Olsen Duane A | Colloidal gold particle concentration immunoassay |
| GB8800702D0 (en) * | 1988-01-13 | 1988-02-10 | Nycomed As | Test method & reagent kit therefor |
| US5162863A (en) * | 1988-02-15 | 1992-11-10 | Canon Kabushiki Kaisha | Method and apparatus for inspecting a specimen by optical detection of antibody/antigen sensitized carriers |
| NO164622C (no) * | 1988-05-11 | 1990-10-24 | Tore Lindmo | Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav. |
| US5079172A (en) * | 1988-11-04 | 1992-01-07 | Board Of Trustees Operating Michigan State University | Method for detecting the presence of antibodies using gold-labeled antibodies and test kit |
| CA2026409C (en) * | 1989-09-29 | 2004-11-09 | Ernest G. Schutt | Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof |
| US5286452A (en) * | 1991-05-20 | 1994-02-15 | Sienna Biotech, Inc. | Simultaneous multiple assays |
-
1993
- 1993-06-15 TW TW082104758A patent/TW239881B/zh active
- 1993-12-21 CN CN93119931A patent/CN1061142C/zh not_active Expired - Fee Related
- 1993-12-22 AU AU58734/94A patent/AU670489B2/en not_active Ceased
- 1993-12-22 EP EP94904875A patent/EP0676045A4/en not_active Withdrawn
- 1993-12-22 KR KR1019950702661A patent/KR0171452B1/ko not_active IP Right Cessation
- 1993-12-22 CA CA002151060A patent/CA2151060A1/en not_active Abandoned
- 1993-12-22 WO PCT/US1993/012428 patent/WO1994015193A1/en not_active Application Discontinuation
- 1993-12-22 JP JP6515382A patent/JPH08505231A/ja active Pending
-
1994
- 1994-08-05 US US08/286,778 patent/US5589401A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5589401A (en) | 1996-12-31 |
| AU5873494A (en) | 1994-07-19 |
| EP0676045A1 (en) | 1995-10-11 |
| WO1994015193A1 (en) | 1994-07-07 |
| KR0171452B1 (ko) | 1999-05-01 |
| CA2151060A1 (en) | 1994-07-07 |
| JPH08505231A (ja) | 1996-06-04 |
| AU670489B2 (en) | 1996-07-18 |
| CN1092866A (zh) | 1994-09-28 |
| EP0676045A4 (en) | 1998-02-04 |
| TW239881B (US20060003336A1-20060105-C00008.png) | 1995-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061142C (zh) | 一种基于微粒光散射的免疫分析方法 | |
| AU724443B2 (en) | Assays using reference microparticles | |
| US5405784A (en) | Agglutination method for the determination of multiple ligands | |
| US4521521A (en) | Particle reagent size distribution measurements for immunoassay | |
| McHugh | Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes | |
| US5501949A (en) | Particle bound binding component immunoassay | |
| US5236826A (en) | Immunoassay for the detection or quantitation of an analyte | |
| US5739042A (en) | Method of assay | |
| JP3384805B2 (ja) | 粒子の２つの判別可能な型を用いた検定方法 | |
| US6551788B1 (en) | Particle-based ligand assay with extended dynamic range | |
| WO1987003690A1 (en) | Particle-bound binding component immunoassay | |
| CN112067815B (zh) | 一种检测小分子半抗原的均相免疫方法 | |
| JPS61265571A (ja) | 異なる比重をもつ相補的粒子を用いる遠心の場におけるイムノアツセイ法 | |
| JP2005077301A (ja) | 免疫学的検出担体および測定法 | |
| US4792527A (en) | Method of assaying biologically active substances and labelling agents therefor | |
| AU595899B2 (en) | Method for diagnostic immunoassay by solid phase separation | |
| JPS6336151A (ja) | 微粒子の螢光強度測定による定量方法 | |
| EP1463947A2 (en) | Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma | |
| JPH0468588B2 (US20060003336A1-20060105-C00008.png) | ||
| RU2314827C2 (ru) | Способ получения конъюгата для стереоспецифического анализа | |
| Lentrichia et al. | Immunoassay of digoxin by differential centrifugation. | |
| JP3375739B2 (ja) | 高感度化免疫測定方法 | |
| WO1993005395A1 (en) | Partition assay with coloured particles | |
| JPH1138005A (ja) | 免疫学的測定試薬の製造方法 | |
| JPS60239670A (ja) | 凝集反応を利用した免疫化学的分析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |